Jacobs Levy Equity Management
WGS icon

Jacobs Levy Equity Management’s GeneDx Holdings WGS Stock Holding History

Jacobs Levy Equity Management’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$960K Buy
14,944
+8,304
+125% +$757K ﹤0.01% 715
2025
Q4 		$864K Sell
6,640
-203
-3% -$27.9K ﹤0.01% 707
2025
Q3 		$737K Sell
6,843
-5,622
-45% -$613K ﹤0.01% 768
2025
Q2 		$1.15M Buy
12,465
+6,954
+126% +$546K ﹤0.01% 731
2025
Q1 		$488K Buy
+5,511
New +$478K ﹤0.01% 922
2024
Q4 		– Sell
-67,776
Closed -$2.88M – 1052
2024
Q3 		$2.88M Sell
67,776
-134,287
-66% -$4.54M 0.01% 532
2024
Q2 		$5.28M Hold
202,063
– – 0.02% 446
2024
Q1 		$1.84M Sell
202,063
-111,596
-36% -$670K 0.01% 609
2023
Q4 		$863K Buy
+313,659
New +$729K ﹤0.01% 748

Other funds holding WGS

CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
ZDA
Zweig-DiMenna Associates New York $722M AUM 97.69% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Jacobs Levy Equity Management's WGS Position: Q1 2026 in Review

Jacobs Levy Equity Management increased its GeneDx Holdings (WGS) stake by 125% in Q1 2026, buying an estimated $757K and bringing the position to 14,944 shares worth $960K. The position accounts for ﹤0.01% of the portfolio, ranked #715.

Jacobs Levy Equity Management first reported a position in WGS in Q4 2023 and has held it in 9 quarters since. The position peaked at $5.28M in Q2 2024. 240 funds tracked by Wall St. Rank hold WGS as of Q1 2026.

  • Jacobs Levy Equity Management held 14,944 shares of GeneDx Holdings worth $960K as of Q1 2026.
  • Jacobs Levy Equity Management bought 8,304 GeneDx Holdings shares in Q1 2026, an estimated $757K.
  • GeneDx Holdings made up ﹤0.01% of Jacobs Levy Equity Management's portfolio in Q1 2026, its #715 holding.
  • Jacobs Levy Equity Management first reported a position in GeneDx Holdings in Q4 2023 and has held it in 9 quarters since.
  • Jacobs Levy Equity Management's GeneDx Holdings position peaked at $5.28M in Q2 2024.
  • 240 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2026.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2026, filed 15 May 2026.